Quick Answer
REVIVA PHARMACEUTICALS HOLDINGS, INC. reported Net Income of -$19.86 million for fiscal year 2025.
REVIVA PHARMACEUTICALS HOLDINGS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$19.86M | +33.6% |
| 2024 | -$29.92M | +23.8% |
| 2023 | -$39.26M | -38.9% |
| 2022 | -$28.26M | -231.6% |
| 2021 | -$8.52M | +0.0% |
| 2021 | -$8.52M | -125.2% |
| 2020 | -$3.78M | -712.3% |
| 2020 | $617.9K | +173.0% |
| 2019 | -$846.8K | -247.5% |
| 2019 | $574.1K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.01M | +52.1% | +33.7% |
| June 30, 2025 | -$6.05M | +23.0% | +5.9% |
| March 31, 2025 | -$6.43M | +13.5% | +23.1% |
| September 30, 2024 | -$8.37M | +26.3% | -6.4% |
| June 30, 2024 | -$7.86M | +32.9% | -5.7% |
| March 31, 2024 | -$7.43M | -8.5% | +34.5% |
| September 30, 2023 | -$11.35M | -222.8% | +3.1% |
| June 30, 2023 | -$11.71M | -119.2% | -70.9% |
- REVIVA PHARMACEUTICALS HOLDINGS, INC. showed an increase of +33.6% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, REVIVA PHARMACEUTICALS HOLDINGS, INC.’s net income has declined by 3560.0% (from $574.1 thousand to -$19.86 million).
- The most recent figure is from REVIVA PHARMACEUTICALS HOLDINGS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: